Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The effectiveness of adding a cognitive behavioural therapy aimed at changing lifestyle to an optimal diabetes care system
ISRCTN ISRCTN12666286
ClinicalTrials.gov identifier
Public title The effectiveness of adding a cognitive behavioural therapy aimed at changing lifestyle to an optimal diabetes care system
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis A cognitive behaviour intervention is more effective in achieving behavioural changes and therefore changes in lifestyle and cardiovascular risk profile than usual care in patients with type two diabetes.
Lay summary
Ethics approval Approved by the Medical Ethical Committee of the VU University Medical Center Amsterdam.
Study design Randomised, active controlled, factorial, single blinded trial
Countries of recruitment Netherlands
Disease/condition/study domain Diabetes Mellitus type II (DM type II)
Participants - inclusion criteria 1. Patients with type two diabetes from general practices with the support of a practice nurse
2. Age 40 to 70 years
3. Written informed consent
4. Capable to fill in questionnaires
5. Understanding of Dutch language
6. HbA1c more than 7.0 % and/or Body Mass Index (BMI) more than 27.0 kg/m^2 and/or smoking
Participants - exclusion criteria 1. Unstable endocrine disorders, with the exception of diabetes
2. Malignant disease
3. Treatment with corticosteroids
4. Serious mental impairment, i.e. preventing to understand the study protocol
Anticipated start date 01/09/2005
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material
Target number of participants 300
Interventions Intervention group:
A Cognitive Behavioural Therapy (CBT) which consist of a Motivational Interviewing phase and a Problem Solving Treatment phase. The CBT will be performed by dieticians and diabetes nurses and includes six individual sessions of 30 minutes. This sessions will be performed within a period of 16 weeks.

Usual care group:
Usual care by general practitioner/practice nurse and an annual check-up Diabetes Research Centre as is usual in the optimal care system where the study will be performed.

Both groups will be measured at baseline, at six and at 12 months. Measurements include: demographic patient characteristics, patients' history, diabetes care, clinical patients' characteristics (weight, height, waist circumference, foot inspection, blood pressure, fasting plasma glucose, HbA1c, total cholesterol, High Density Lipoprotein [HDL]-cholesterol) and questionnaires.
Primary outcome measure(s) 1. Differences between intervention and usual care groups in changes in diet, physical activity and smoking behaviour according to the ASE-model, a health behaviour model that assumes that behaviour is determined by attitude (A), social influences (S) and self-efficacy (E)
2. Changes in cardiovascular risk score based on the Oxford Risk Engine (algorithm that includes: age at diagnosis, duration of diabetes, sex, ethnicity, smoking status, systolic blood pressure, HbA1c, total cholesterol, HDL-cholesterol). A risk reduction of 5% is clinical relevant.
Secondary outcome measure(s) 1. Quality of life
2. Patient satisfaction
3. Changes in medication use, adherence to prescribed medication
4. Proportion of patients reaching treatment targets according to the guidelines of the Dutch College of General practitioners
5. Adherence to the 3-monthly visit to the general practitioner
Sources of funding EMGO Institute (The Netherlands) - internal funding
Trial website
Publications Study protocol on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17488511
Contact name Ms  Corina  van den Hurk
  Address Zernikestraat 29
  City/town Eindhoven
  Zip/Postcode 5612 HZ
  Country Netherlands
Sponsor VU University Medical Centre (The Netherlands)
  Address EMGO-Institute
Van der Boechorststraat 7
  City/town Amsterdam
  Zip/Postcode 1081 BT
  Country Netherlands
  Tel +31 (0)20 444 8180
  Fax +31 (0)20 444 8181
  Email emgo@vumc.nl
  Sponsor website: http://www.emgo.nl/
Date applied 12/09/2005
Last edited 14/05/2007
Date ISRCTN assigned 12/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central